Marel hf (MAREL.AS)

IS0000000388 - Common Stock

4.55  +0.12 (+2.71%)

Fundamental Rating

2

Taking everything into account, MAREL scores 2 out of 10 in our fundamental rating. MAREL was compared to 105 industry peers in the Machinery industry. MAREL has a bad profitability rating. Also its financial health evaluation is rather negative. MAREL has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

MAREL had positive earnings in the past year.
MAREL had a positive operating cash flow in the past year.
In the past 5 years MAREL has always been profitable.
MAREL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of MAREL (0.44%) is worse than 63.00% of its industry peers.
The Return On Equity of MAREL (1.10%) is worse than 61.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.55%, MAREL is doing worse than 64.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MAREL is below the industry average of 8.50%.
Industry RankSector Rank
ROA 0.44%
ROE 1.1%
ROIC 3.55%
ROA(3y)2.73%
ROA(5y)3.95%
ROE(3y)6.07%
ROE(5y)8.09%
ROIC(3y)5.23%
ROIC(5y)6.94%

1.3 Margins

MAREL has a worse Profit Margin (0.69%) than 62.00% of its industry peers.
In the last couple of years the Profit Margin of MAREL has declined.
Looking at the Operating Margin, with a value of 5.21%, MAREL is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of MAREL has declined.
Looking at the Gross Margin, with a value of 36.06%, MAREL is in line with its industry, outperforming 42.00% of the companies in the same industry.
In the last couple of years the Gross Margin of MAREL has declined.
Industry RankSector Rank
OM 5.21%
PM (TTM) 0.69%
GM 36.06%
OM growth 3Y-23.73%
OM growth 5Y-17.24%
PM growth 3Y-39.86%
PM growth 5Y-29.33%
GM growth 3Y-2.31%
GM growth 5Y-2.35%

2

2. Health

2.1 Basic Checks

MAREL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MAREL has about the same amout of shares outstanding than it did 1 year ago.
MAREL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MAREL has remained at the same level compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.59 indicates that MAREL is not a great score, but indicates only limited risk for bankruptcy at the moment.
MAREL has a Altman-Z score of 2.59. This is in the better half of the industry: MAREL outperforms 65.00% of its industry peers.
MAREL has a debt to FCF ratio of 17.03. This is a negative value and a sign of low solvency as MAREL would need 17.03 years to pay back of all of its debts.
MAREL has a worse Debt to FCF ratio (17.03) than 63.00% of its industry peers.
A Debt/Equity ratio of 0.84 indicates that MAREL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.84, MAREL is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 17.03
Altman-Z 2.59
ROIC/WACC0.64
WACC5.55%

2.3 Liquidity

A Current Ratio of 1.36 indicates that MAREL should not have too much problems paying its short term obligations.
MAREL's Current ratio of 1.36 is on the low side compared to the rest of the industry. MAREL is outperformed by 65.00% of its industry peers.
MAREL has a Quick Ratio of 1.36. This is a bad value and indicates that MAREL is not financially healthy enough and could expect problems in meeting its short term obligations.
MAREL's Quick ratio of 0.77 is on the low side compared to the rest of the industry. MAREL is outperformed by 69.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.77

3

3. Growth

3.1 Past

The earnings per share for MAREL have decreased strongly by -72.06% in the last year.
MAREL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -25.45% yearly.
Looking at the last year, MAREL shows a decrease in Revenue. The Revenue has decreased by -5.67% in the last year.
The Revenue has been growing slightly by 7.52% on average over the past years.
EPS 1Y (TTM)-72.06%
EPS 3Y-32.75%
EPS 5Y-25.45%
EPS Q2Q%-62.39%
Revenue 1Y (TTM)-5.67%
Revenue growth 3Y11.62%
Revenue growth 5Y7.52%
Sales Q2Q%-4.14%

3.2 Future

MAREL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.00% yearly.
The Revenue is expected to grow by 4.44% on average over the next years.
EPS Next Y45.24%
EPS Next 2Y45.57%
EPS Next 3Y39%
EPS Next 5YN/A
Revenue Next Year0.51%
Revenue Next 2Y2.98%
Revenue Next 3Y3.98%
Revenue Next 5Y4.44%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 227.50, MAREL can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MAREL indicates a slightly more expensive valuation: MAREL is more expensive than 66.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MAREL to the average of the S&P500 Index (27.40), we can say MAREL is valued expensively.
A Price/Forward Earnings ratio of 29.78 indicates a quite expensive valuation of MAREL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MAREL indicates a slightly more expensive valuation: MAREL is more expensive than 78.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MAREL to the average of the S&P500 Index (23.67), we can say MAREL is valued slightly more expensively.
Industry RankSector Rank
PE 227.5
Fwd PE 29.78

4.2 Price Multiples

76.00% of the companies in the same industry are cheaper than MAREL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MAREL is valued a bit more expensive than 67.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 67.72
EV/EBITDA 23.03

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MAREL does not grow enough to justify the current Price/Earnings ratio.
MAREL's earnings are expected to grow with 39.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.03
PEG (5Y)N/A
EPS Next 2Y45.57%
EPS Next 3Y39%

2

5. Dividend

5.1 Amount

MAREL has a yearly dividend return of 0.19%, which is pretty low.
MAREL's Dividend Yield is comparable with the industry average which is at 3.21.
Compared to an average S&P500 Dividend Yield of 2.33, MAREL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

The dividend of MAREL decreases each year by -18.19%.
Dividend Growth(5Y)-18.19%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MAREL pays out 54.39% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP54.39%
EPS Next 2Y45.57%
EPS Next 3Y39%

Marel hf

AMS:MAREL (1/3/2025, 7:00:00 PM)

4.55

+0.12 (+2.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30 2024-10-30
Earnings (Next)02-12 2025-02-12/amc
Inst Owners39.57%
Inst Owner ChangeN/A
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap3.51B
Analysts84
Price Target0.03 (-99.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Dividend Growth(5Y)-18.19%
DP54.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.68%
PT rev (3m)14.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)12.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 227.5
Fwd PE 29.78
P/S 2.11
P/FCF 67.72
P/OCF 34.36
P/B 3.39
P/tB N/A
EV/EBITDA 23.03
EPS(TTM)0.02
EY0.44%
EPS(NY)0.15
Fwd EY3.36%
FCF(TTM)0.07
FCFY1.48%
OCF(TTM)0.13
OCFY2.91%
SpS2.16
BVpS1.34
TBVpS-0.44
PEG (NY)5.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.1%
ROCE 4.33%
ROIC 3.55%
ROICexc 3.67%
ROICexgc 12.7%
OM 5.21%
PM (TTM) 0.69%
GM 36.06%
FCFM 3.12%
ROA(3y)2.73%
ROA(5y)3.95%
ROE(3y)6.07%
ROE(5y)8.09%
ROIC(3y)5.23%
ROIC(5y)6.94%
ROICexc(3y)5.48%
ROICexc(5y)7.75%
ROICexgc(3y)24.97%
ROICexgc(5y)39.54%
ROCE(3y)6.38%
ROCE(5y)8.46%
ROICexcg growth 3Y-34.3%
ROICexcg growth 5Y-33.18%
ROICexc growth 3Y-26.23%
ROICexc growth 5Y-21.39%
OM growth 3Y-23.73%
OM growth 5Y-17.24%
PM growth 3Y-39.86%
PM growth 5Y-29.33%
GM growth 3Y-2.31%
GM growth 5Y-2.35%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 17.03
Debt/EBITDA 4.63
Cap/Depr 49.7%
Cap/Sales 3.03%
Interest Coverage 1.43
Cash Conversion 54.34%
Profit Quality 454.39%
Current Ratio 1.36
Quick Ratio 0.77
Altman-Z 2.59
F-Score5
WACC5.55%
ROIC/WACC0.64
Cap/Depr(3y)100.26%
Cap/Depr(5y)91.26%
Cap/Sales(3y)5.13%
Cap/Sales(5y)4.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.06%
EPS 3Y-32.75%
EPS 5Y-25.45%
EPS Q2Q%-62.39%
EPS Next Y45.24%
EPS Next 2Y45.57%
EPS Next 3Y39%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.67%
Revenue growth 3Y11.62%
Revenue growth 5Y7.52%
Sales Q2Q%-4.14%
Revenue Next Year0.51%
Revenue Next 2Y2.98%
Revenue Next 3Y3.98%
Revenue Next 5Y4.44%
EBIT growth 1Y-18.13%
EBIT growth 3Y-14.87%
EBIT growth 5Y-11.02%
EBIT Next Year83.77%
EBIT Next 3Y32.66%
EBIT Next 5Y29.2%
FCF growth 1Y333.33%
FCF growth 3Y-25.94%
FCF growth 5Y-13.88%
OCF growth 1Y47.33%
OCF growth 3Y-8.89%
OCF growth 5Y-3.71%